WRITING COMMITTEE MEMBERS Scott M. Grundy, MD, PhD, FAHA, Chair* Neil J. Stone, MD, FACC, FAHA, Vice Chair* Alison L. Bailey, MD, FACC, FAACVPR Craig Beam, CRE* Kim K. Birtcher, MS, PharmD, AACC, FNLA Roger S. Blumenthal, MD, FACC, FAHA, FNLA Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FNLA Sarah de Ferranti, MD, MPH* Joseph Faiella-Tommasino, PhD, PA-C Daniel E. Forman, MD, FAHA** Ronald Goldberg, MD Paul A. Heidenreich, MD, MS, FACC, FAHA Mark A. Hlatky, MD, FACC, FAHA* Daniel W. Jones, MD, FAHA Donald Lloyd-Jones, MD, SCM, FACC, FAHA* Nuria Lopez-Pajares, MD, MPH Chiadi E. Ndumele, MD, PhD, FAHA* Carl E. Orringer, MD, FACC, FNLA Carmen A. Peralta, MD, MAS* Joseph J. Saseen, PharmD, FNLA, FAHA Sidney C. Smith Jr, MD, MACC, FAHA* Laurence Sperling, MD, FACC, FAHA, FASPC*** Salim S. Virani, MD, PhD, FACC, FAHA* Joseph Yeboah, MD, MS, FACC, FAHA 2018 by the American Heart Association, Inc., and the American College of Cardiology Foundation. CHOLESTEROL CLINICAL PRACTICE GUIDELINES AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Circulation https://www.ahajournals.org/journal/circ ACC/AHA Task Force Members, see page e1123 *ACC/AHA Representative. AACVPR Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Prevention Subcommittee Liaison. PCNA Representative. AAPA Representative. **AGS Representative. ADA Representative. PM Representative. ACPM Representative. NLA Representative. APhA Representative. ***ASPC Representative. ABC Representative. The American Heart Association requests that this document be cited as follows: Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 